Fink S P, Reddy G R, Marnett L J
Department of Biochemistry, Center in Molecular Toxicology and The Vanderbilt Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232-0146, USA.
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8652-7. doi: 10.1073/pnas.94.16.8652.
The spectrum of mutations induced by the naturally occurring DNA adduct pyrimido[1,2-alpha]purin-10(3H)-one (M1G) was determined by site-specific approaches using M13 vectors replicated in Escherichia coli. M1G was placed at position 6256 in the (-)-strand of M13MB102 by ligating the oligodeoxynucleotide 5'-GGT(M1G)TCCG-3' into a gapped-duplex derivative of the vector. Unmodified and M1G-modified genomes containing either a cytosine or thymine at position 6256 of the (+)-strand were transformed into repair-proficient and repair-deficient E. coli strains, and base pair substitutions were quantitated by hybridization analysis. Modified genomes containing a cytosine opposite M1G resulted in roughly equal numbers of M1G-->A and M1G-->T mutations with few M1G-->C mutations. The total mutation frequency was approximately 1%, which represents a 500-fold increase in mutations compared with unmodified M13MB102. Transformation of modified genomes containing a thymine opposite M1G allowed an estimate to be made of the ability of M1G to block replication. The (-)-strand was replicated >80% of the time in the unadducted genome but only 20% of the time when M1G was present. Correction of the mutation frequency for the strand bias of replication indicated that the actual frequency of mutations induced by M1G was 18%. Experiments using E. coli with different genetic backgrounds indicated that the SOS response enhances the mutagenicity of M1G and that M1G is a substrate for repair by the nucleotide excision repair complex. These studies indicate that M1G, which is present endogenously in DNA of healthy human beings, is a strong block to replication and an efficient premutagenic lesion.
通过使用在大肠杆菌中复制的M13载体的位点特异性方法,确定了天然存在的DNA加合物嘧啶并[1,2-α]嘌呤-10(3H)-酮(M1G)诱导的突变谱。通过将寡脱氧核苷酸5'-GGT(M1G)TCCG-3'连接到载体的缺口双链衍生物中,将M1G置于M13MB102(-)链的6256位。将在(+)链6256位含有胞嘧啶或胸腺嘧啶的未修饰和M1G修饰的基因组转化到修复 proficient 和修复缺陷的大肠杆菌菌株中,并通过杂交分析对碱基对替换进行定量。与M1G相对含有胞嘧啶的修饰基因组导致M1G→A和M1G→T突变的数量大致相等,而M1G→C突变很少。总突变频率约为1%,与未修饰的M13MB102相比,突变增加了500倍。转化与M1G相对含有胸腺嘧啶的修饰基因组,可以估计M1G阻断复制的能力。在未加合物的基因组中,(-)链80%以上的时间被复制,但当存在M1G时,只有20%的时间被复制。对复制链偏倚的突变频率进行校正表明,M1G诱导的实际突变频率为18%。使用具有不同遗传背景的大肠杆菌进行的实验表明,SOS反应增强了M1G的诱变性,并且M1G是核苷酸切除修复复合物修复的底物。这些研究表明,健康人类DNA中内源性存在的M1G是复制的强阻断剂和有效的前诱变损伤。